19-11113505-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000527.5(LDLR):​c.1359-30C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.428 in 1,612,554 control chromosomes in the GnomAD database, including 155,431 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.34 ( 11031 hom., cov: 30)
Exomes 𝑓: 0.44 ( 144400 hom. )

Consequence

LDLR
NM_000527.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -0.637

Publications

41 publications found
Variant links:
Genes affected
LDLR (HGNC:6547): (low density lipoprotein receptor) The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. The encoded protein is normally bound at the cell membrane, where it binds low density lipoprotein/cholesterol and is taken into the cell. Lysosomes release the cholesterol, which is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2022]
MIR6886 (HGNC:50121): (microRNA 6886) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 19-11113505-C-T is Benign according to our data. Variant chr19-11113505-C-T is described in ClinVar as Benign. ClinVar VariationId is 251806.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.447 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000527.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LDLR
NM_000527.5
MANE Select
c.1359-30C>T
intron
N/ANP_000518.1P01130-1
LDLR
NM_001195798.2
c.1359-30C>T
intron
N/ANP_001182727.1P01130-5
LDLR
NM_001195799.2
c.1236-30C>T
intron
N/ANP_001182728.1P01130-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LDLR
ENST00000558518.6
TSL:1 MANE Select
c.1359-30C>T
intron
N/AENSP00000454071.1P01130-1
LDLR
ENST00000252444.10
TSL:1
c.1617-30C>T
intron
N/AENSP00000252444.6J3KMZ9
LDLR
ENST00000558013.5
TSL:1
c.1359-30C>T
intron
N/AENSP00000453346.1P01130-5

Frequencies

GnomAD3 genomes
AF:
0.342
AC:
51991
AN:
151818
Hom.:
11044
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0908
Gnomad AMI
AF:
0.349
Gnomad AMR
AF:
0.438
Gnomad ASJ
AF:
0.456
Gnomad EAS
AF:
0.171
Gnomad SAS
AF:
0.392
Gnomad FIN
AF:
0.506
Gnomad MID
AF:
0.446
Gnomad NFE
AF:
0.451
Gnomad OTH
AF:
0.368
GnomAD2 exomes
AF:
0.398
AC:
99474
AN:
250150
AF XY:
0.405
show subpopulations
Gnomad AFR exome
AF:
0.0825
Gnomad AMR exome
AF:
0.422
Gnomad ASJ exome
AF:
0.467
Gnomad EAS exome
AF:
0.173
Gnomad FIN exome
AF:
0.494
Gnomad NFE exome
AF:
0.449
Gnomad OTH exome
AF:
0.420
GnomAD4 exome
AF:
0.437
AC:
638051
AN:
1460618
Hom.:
144400
Cov.:
37
AF XY:
0.436
AC XY:
317033
AN XY:
726604
show subpopulations
African (AFR)
AF:
0.0754
AC:
2524
AN:
33454
American (AMR)
AF:
0.426
AC:
19018
AN:
44668
Ashkenazi Jewish (ASJ)
AF:
0.469
AC:
12249
AN:
26130
East Asian (EAS)
AF:
0.143
AC:
5682
AN:
39692
South Asian (SAS)
AF:
0.394
AC:
33937
AN:
86228
European-Finnish (FIN)
AF:
0.483
AC:
25608
AN:
53048
Middle Eastern (MID)
AF:
0.449
AC:
2589
AN:
5762
European-Non Finnish (NFE)
AF:
0.460
AC:
511265
AN:
1111266
Other (OTH)
AF:
0.417
AC:
25179
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
19583
39166
58750
78333
97916
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15104
30208
45312
60416
75520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.342
AC:
51967
AN:
151936
Hom.:
11031
Cov.:
30
AF XY:
0.346
AC XY:
25688
AN XY:
74250
show subpopulations
African (AFR)
AF:
0.0905
AC:
3755
AN:
41480
American (AMR)
AF:
0.437
AC:
6661
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.456
AC:
1582
AN:
3468
East Asian (EAS)
AF:
0.171
AC:
879
AN:
5146
South Asian (SAS)
AF:
0.391
AC:
1887
AN:
4824
European-Finnish (FIN)
AF:
0.506
AC:
5339
AN:
10546
Middle Eastern (MID)
AF:
0.435
AC:
128
AN:
294
European-Non Finnish (NFE)
AF:
0.451
AC:
30646
AN:
67926
Other (OTH)
AF:
0.366
AC:
773
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1538
3077
4615
6154
7692
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
506
1012
1518
2024
2530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.351
Hom.:
2446
Bravo
AF:
0.325
Asia WGS
AF:
0.267
AC:
929
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
Hypercholesterolemia, familial, 1 (6)
-
-
2
not provided (2)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Familial hypercholesterolemia (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
4.3
DANN
Benign
0.79
PhyloP100
-0.64
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1003723; hg19: chr19-11224181; COSMIC: COSV52944860; COSMIC: COSV52944860; API